Looking for new technology - Biomarkers HDL Function
As a large multinational corporation operating in the healthcare sector, we are looking for certain new technologies to license or acquire.
As a fortune 500 multinational corporation operating in the healthcare sector, we are looking for certain new technologies to license or acquire. If you have technologies in these areas, we welcome you to get in touch via Tynax. We have the sales channels to effectively bring new healthcare products to market.
We are keenly aware of and continuously review discoveries and developments across the entire drug discovery and development community. To achieve this, our Review and Licensing Committees, each target a specific therapeutic area or technology. This means that we provide a formal review and response for every viable opportunity.
Areas of Interest:
- Platforms for measuring HDL-medicated reverse cholesterol transport, preclinically and clinically, including imaging and kinetic models.
- Platforms for determining protein or lipid composition of HDL.
Not Interested in:
- In vitro reverse cholesterol transport assays.
Patents and Intellectual Property
We will only consider technology covered by a patent.
Deal Structure, Licensing and Ownership of Intellectual Property
We are looking to buy this technology.
View this listing on the Tynax website: www.tynax.com/techwantedlisting/30